Skip to main content
WSTN
NASDAQ Life Sciences

SPAC Westin Acquisition to Take First Choice Healthcare Public in $650M Deal

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Industrial
Sentiment info
Positive
Importance info
9
Price
$10.12
Mkt Cap
$81.517M
52W Low
$9.89
52W High
$10.13
52W Position info
2.3% above low
Off High info
at 52W high
Rel. Volume
Market data snapshot near publication time

WSTN is trading near its 52-week low of $9.89 (2.3% above the low).

Summary

Westin Acquisition, a SPAC trading near its 52-week high, announced a definitive business combination agreement to take First Choice Healthcare Solutions public at a pro forma enterprise value of about $650 million. The combined company will rebrand as Wellgevity 360 and trade on Nasdaq after closing, expected in Q4 2026. This is a transformative event for the SPAC, which had previously disclosed substantial doubt about its ability to continue as a going concern. The deal provides a clear path to a business combination in the functional health and longevity space. The announcement is the first material update since the May 10-Q flagged going concern risks, making it a significant positive catalyst.

At the time of this announcement, WSTN was trading at $10.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $81.5M. The 52-week trading range was $9.89 to $10.13. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

WSTN - Latest Insights

WSTN
May 15, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $10.03
Real-time Price: $10.12 info
Change: +$0.090 (+0.90%) info
Market Cap: $81.517M info
WSTN
Feb 13, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.97
Real-time Price: $10.12 info
Change: +$0.150 (+2%) info
Market Cap: $81.517M info